Generic price reporting lawsuit

Executive Summary

Generic Pharmaceutical Association criticizes Massachusetts Attorney General's Sept. 25 civil lawsuit against 13 generic firms regarding fraudulent price reporting. The suit is "counter-productive when more constructive ways of seeking lower spending, such as increasing generic pharmaceutical utilization and access to generic medicines, can deliver immediate and substantial additional savings to consumers and state governments," GPhA says. Massachusetts claims the state Medicaid program lost over $50 mil. due to drug "marketing and pricing schemes"...